Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-08-29

FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Vensun Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for levocetirizine dihydrochloride from Vensun Pharmaceuticals, Inc., finalizing an update to an approved generic pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levocetirizine dihydrochloride (LEVOCETIRIZINE DIHYDROCHLORIDE)

Snippet

SUPPL AP for LEVOCETIRIZINE DIHYDROCHLORIDE (LEVOCETIRIZINE DIHYDROCHLORIDE)